• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

摄入索利那新而非托特罗定或达非那新的人尿液可阻断逼尿肌过度活动。

Human urine with solifenacin intake but not tolterodine or darifenacin intake blocks detrusor overactivity.

作者信息

Chuang Yao-Chi, Thomas Catherine A, Tyagi Shachi, Yoshimura Naoki, Tyagi Pradeep, Chancellor Michael B

机构信息

Department of Urology, Chang Gung Memorial Hospital, Kaohsiung Medical Center, Chang Gung University College of Medicine, 123, Ta-Pei Road, Niao-Song Hsiang, Kaohsiung Hsien, Taiwan.

出版信息

Int Urogynecol J Pelvic Floor Dysfunct. 2008 Oct;19(10):1353-7. doi: 10.1007/s00192-008-0650-7. Epub 2008 May 27.

DOI:10.1007/s00192-008-0650-7
PMID:18504514
Abstract

The objective of the study was to evaluate the local effects of three antimuscarinics excreted into human urine after oral ingestion. Two normal adult collected their voided urine after taking oral doses of tolterodine, darifenacin, and solifenacin for 7 days with a 14-day washout period. The urodynamic effect of intravesically administered human urine on carbachol-induced bladder overactivity was studied in female rats. Cystometric parameters were measured during continuous infusion of saline and human urine and then a mixture of carbachol (30 microM) and human urine. Carbachol significantly reduced the intercontraction interval and bladder capacity in the control (urine taken in the absence of oral antimuscarinics) and tolterodine- or darifenacin-administered groups. However, human urine obtained after taking solifenacin prevented the carbachol-induced detrusor overactivity. Urine excreted after oral ingestion of solifenacin provides a localized pharmacological advantage for the treatment of the overactive bladder syndrome.

摘要

本研究的目的是评估口服摄入后排泄到人体尿液中的三种抗毒蕈碱药物的局部作用。两名正常成年人在口服托特罗定、达非那新和索利那新7天,并经过14天的洗脱期后,收集其排尿。在雌性大鼠中研究了膀胱内注入人尿对卡巴胆碱诱导的膀胱过度活动的尿动力学作用。在持续输注生理盐水和人尿,然后是卡巴胆碱(30微摩尔)与人尿的混合物期间,测量膀胱测压参数。在对照组(未服用口服抗毒蕈碱药物时采集的尿液)以及服用托特罗定或达非那新的组中,卡巴胆碱显著缩短了收缩间期并降低了膀胱容量。然而,服用索利那新后获得的人尿可预防卡巴胆碱诱导的逼尿肌过度活动。口服索利那新后排泄的尿液为治疗膀胱过度活动症提供了局部药理学优势。

相似文献

1
Human urine with solifenacin intake but not tolterodine or darifenacin intake blocks detrusor overactivity.摄入索利那新而非托特罗定或达非那新的人尿液可阻断逼尿肌过度活动。
Int Urogynecol J Pelvic Floor Dysfunct. 2008 Oct;19(10):1353-7. doi: 10.1007/s00192-008-0650-7. Epub 2008 May 27.
2
Intravesical instillation of human urine after oral administration of trospium, tolterodine and oxybutynin in a rat model of detrusor overactivity.在膀胱过度活动症大鼠模型中口服曲司氯铵、托特罗定和奥昔布宁后进行人尿膀胱内灌注。
BJU Int. 2006 Feb;97(2):400-3. doi: 10.1111/j.1464-410X.2005.05913.x.
3
Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents.新型抗毒蕈碱药物琥珀酸索利那新与其他抗毒蕈碱药物的药理学特性比较
Biol Pharm Bull. 2007 Jan;30(1):54-8. doi: 10.1248/bpb.30.54.
4
Comparison of in vitro selectivity profiles of solifenacin succinate (YM905) and current antimuscarinic drugs in bladder and salivary glands: a Ca2+ mobilization study in monkey cells.琥珀酸索利那新(YM905)与目前抗毒蕈碱药物在膀胱和唾液腺中的体外选择性概况比较:一项在猴细胞中的钙离子动员研究。
Life Sci. 2004 Jan 2;74(7):843-53. doi: 10.1016/j.lfs.2003.07.019.
5
The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction.4型磷酸二酯酶抑制剂和毒蕈碱胆碱能拮抗剂酒石酸托特罗定对膀胱出口梗阻雌性大鼠逼尿肌过度活动的影响。
BJU Int. 2008 Mar;101(5):615-20. doi: 10.1111/j.1464-410X.2007.07307.x. Epub 2007 Dec 7.
6
Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists.托特罗定与亚型选择性毒蕈碱受体拮抗剂的体外和体内特征比较。
Eur J Pharmacol. 1998 May 22;349(2-3):285-92. doi: 10.1016/s0014-2999(98)00214-3.
7
Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways.抗毒蕈碱药物对膀胱传入通路中的毒蕈碱受体具有局部抑制作用。
Urology. 2005 Feb;65(2):238-42. doi: 10.1016/j.urology.2004.11.021.
8
In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats.大鼠体内外琥珀酸索利那新(YM905)对膀胱相对于唾液腺的组织选择性概况
Eur J Pharmacol. 2004 May 25;492(2-3):243-50. doi: 10.1016/j.ejphar.2004.03.044.
9
A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder.抗毒蕈碱药物治疗膀胱过度活动症的中枢神经系统穿透潜力的全面非临床评估。
Br J Clin Pharmacol. 2011 Aug;72(2):235-46. doi: 10.1111/j.1365-2125.2011.03961.x.
10
Urothelial/lamina propria spontaneous activity and the role of M3 muscarinic receptors in mediating rate responses to stretch and carbachol.尿路上皮/固有层自发性活动和 M3 毒蕈碱受体在介导伸展和卡巴胆碱反应率中的作用。
Urology. 2011 Dec;78(6):1442.e9-15. doi: 10.1016/j.urology.2011.08.039. Epub 2011 Oct 15.

引用本文的文献

1
Urine: Waste product or biologically active tissue?尿液:废物产物还是具有生物活性的组织?
Neurourol Urodyn. 2018 Mar;37(3):1162-1168. doi: 10.1002/nau.23414. Epub 2018 Feb 21.
2
Intravesical liposome and antisense treatment for detrusor overactivity and interstitial cystitis/painful bladder syndrome.膀胱内脂质体和反义疗法治疗逼尿肌过度活动症和间质性膀胱炎/膀胱疼痛综合征。
ISRN Pharmacol. 2014 Jan 15;2014:601653. doi: 10.1155/2014/601653. eCollection 2014.
3
Safety and tolerability profiles of anticholinergic agents used for the treatment of overactive bladder.

本文引用的文献

1
Muscarinic receptor antagonists for overactive bladder.用于治疗膀胱过度活动症的毒蕈碱受体拮抗剂。
BJU Int. 2007 Nov;100(5):987-1006. doi: 10.1111/j.1464-410X.2007.07205.x.
2
Effects of the M3 receptor selective muscarinic antagonist darifenacin on bladder afferent activity of the rat pelvic nerve.M3受体选择性毒蕈碱拮抗剂达非那新对大鼠盆神经膀胱传入活动的影响。
Eur Urol. 2007 Sep;52(3):842-7. doi: 10.1016/j.eururo.2007.02.057. Epub 2007 Mar 6.
3
Treatment of the overactive bladder syndrome with muscarinic receptor antagonists: a matter of metabolites?
用于治疗膀胱过度活动症的抗胆碱能药物的安全性和耐受性概况。
Drug Saf. 2011 Sep 1;34(9):733-54. doi: 10.2165/11592790-000000000-00000.
4
Functional role of cannabinoid receptors in urinary bladder.大麻素受体在膀胱中的功能作用。
Indian J Urol. 2010 Jan-Mar;26(1):26-35. doi: 10.4103/0970-1591.60440.
5
Urothelial effects of oral agents for overactive bladder.治疗膀胱过度活动症口服药物对尿路上皮的影响
Curr Urol Rep. 2008 Nov;9(6):459-64. doi: 10.1007/s11934-008-0079-z.
用毒蕈碱受体拮抗剂治疗膀胱过度活动症:与代谢物有关?
Naunyn Schmiedebergs Arch Pharmacol. 2006 Nov;374(2):79-85. doi: 10.1007/s00210-006-0105-y.
4
Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions?抗毒蕈碱药物治疗逼尿肌过度活动症和膀胱过度活动症:是运动作用还是感觉作用?
BJU Int. 2006 Sep;98(3):503-7. doi: 10.1111/j.1464-410X.2006.06258.x.
5
Intravesical instillation of human urine after oral administration of trospium, tolterodine and oxybutynin in a rat model of detrusor overactivity.在膀胱过度活动症大鼠模型中口服曲司氯铵、托特罗定和奥昔布宁后进行人尿膀胱内灌注。
BJU Int. 2006 Feb;97(2):400-3. doi: 10.1111/j.1464-410X.2005.05913.x.
6
Augmented extracellular ATP signaling in bladder urothelial cells from patients with interstitial cystitis.间质性膀胱炎患者膀胱尿路上皮细胞中细胞外ATP信号增强。
Am J Physiol Cell Physiol. 2006 Jan;290(1):C27-34. doi: 10.1152/ajpcell.00552.2004. Epub 2005 Aug 17.
7
A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial.琥珀酸索利那新与托特罗定缓释制剂治疗膀胱过度活动症的疗效及耐受性比较:STAR试验结果
Eur Urol. 2005 Sep;48(3):464-70. doi: 10.1016/j.eururo.2005.05.015.
8
The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis.抗毒蕈碱治疗对膀胱过度活动症的影响:一项系统评价与荟萃分析。
Eur Urol. 2005 Jul;48(1):5-26. doi: 10.1016/j.eururo.2005.02.024. Epub 2005 Mar 22.
9
Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing.通过放射性配体结合和定量竞争性逆转录聚合酶链反应研究人膀胱逼尿肌和黏膜中的毒蕈碱受体亚型:衰老过程中的变化
Br J Pharmacol. 2005 Apr;144(8):1089-99. doi: 10.1038/sj.bjp.0706147.
10
Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways.抗毒蕈碱药物对膀胱传入通路中的毒蕈碱受体具有局部抑制作用。
Urology. 2005 Feb;65(2):238-42. doi: 10.1016/j.urology.2004.11.021.